Schering-Plough Corp. is focusing on key regions and countries through a number of strategic actions in the company’s Global Pharmaceutical Business. The changes are part of the company’s six- to eight-year Action Agenda to transform itself into a global high performance competitor for the long-term. These changes come as the company works to deliver the 12- to 18-month Turnaround Phase that began in October 2005. Schering-Plough has restructured its Europe-based regional organi...